Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2018-11-07
2019-04-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this research, a total of 90 eligible and consenting participants will be randomly allocated to consume three portions per week of n-3 enriched beef (from either dietary supplemented or grass-fed cattle) or control beef (from standard supply). This beef will be offered within a lunchtime meal and served from the Human Intervention Studies Unit at Ulster University, Coleraine for a period of 5 weeks. A fasting blood sample will be taken before and after intervention to determine the effect the n-3 enriched beef on cholesterol concentrations, lipid profile, PUFA status and inflammation. Blood pressure, stiffness of the arteries and body shape, size and composition will also be assessed, and some health and lifestyle habits will be captured using questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impacts of Omega-3-PUFA Enriched Chicken-meat and Eggs in Healthy Humans
NCT04127409
N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet and Cardiovascular Function
NCT05725486
Omega-3-Index Response to Eating Poultry Foods Naturally Enriched With Omega-3 Polyunsaturated Fatty Acids
NCT06259825
Polyunsaturated Fatty Acids Supplementation and Blood Metabolome
NCT03892486
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beef from standard supply
Three portions per week (690g beef (raw weight)) for 5 weeks
Lunches served in Human Intervention Studies Unit
n-3 enriched beef from dietary supplement finished cattle
Three portions per week (690g beef (raw weight)) for 5 weeks
Lunches served in Human Intervention Studies Unit
n-3 enriched beef from grass finished cattle
Three portions per week (690g beef (raw weight)) for 5 weeks
Lunches served in Human Intervention Studies Unit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Three portions per week (690g beef (raw weight)) for 5 weeks
Lunches served in Human Intervention Studies Unit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 20+ years at recruitment
* Low oily fish consumers (\<2 servings/mo), or those willing to reduce their fish consumption 1 month prior to commencing the study
* Non-smokers
* Not regularly consuming plant stanols or other n-3 enriched foodstuffs
Exclusion Criteria
* Adults \<20 years at recruitment
* Oily fish consumers (2 servings/mo or more)
* Current smokers
* Pregnant/lactating females (or planning to become pregnant)
* Food allergy or intolerance that would prevent consumption of the study meals
* Diagnosed with a chronic medical condition (such as diabetes; CVD; autoimmune/ inflammatory disorders; cancer)
* Prescribed cholesterol or blood pressure lowering medications
* Currently taking any fish oil-containing supplement Daily consumption of plant stanols or other n-3 enriched foodstuffs
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dunbia, Northern Ireland
UNKNOWN
University of Ulster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Intervention Studies Unit, Ulster University
Coleraine, Co.Londonderry, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/WS/0149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.